GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M

Main Category: Medicare / Medicaid / SCHIP
Also Included In: Pharma Industry / Biotech Industry;  Litigation / Medical Malpractice
Article Date: 03 Jul 2008 - 6:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:not yet rated

Healthcare Prof:4 and a half stars

4.5 (2 votes)


An Alabama state court jury on Tuesday found pharmaceutical companies GlaxoSmithKline and Novartis guilty of defrauding the state Medicaid program by charging artificially high prices for medications and ordered the two companies to pay more than $114 million in restitution, the AP/Minneapolis Star Tribune reports. GSK was ordered to pay the state $80.8 million and Novartis about $33.7 million in compensatory damages.

State attorneys claimed the companies charged the Medicaid program one price for drugs while offering discounted prices to private insurers from 1991 to 2005 and asked that the companies pay as much as $800 million in total damages. Lawyers for GSK and Novartis argued the companies followed proper procedures in setting drug prices. Jere Beasley, a lawyer representing the state, said, "I think the jury looked at the evidence and decided the fraud was substantial but that the compensatory damages plus interest was enough." Beasley added that the decision could help other states settle similar lawsuits with pharmaceutical companies.

Attorneys for both firms said they were considering appealing the decision. "It's been our position all along that GSK reported true and accurate prices," Don Jones, an attorney representing GSK, said. Harlan Prater, an attorney representing Novartis, said, "We're grateful that the jury did not find the punitive damages were warranted. We believe we reported appropriate prices" (Johnson, AP/Minneapolis Star Tribune, 7/1).

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our medicare / medicaid / schip section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Kaiser. "GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M." Medical News Today. MediLexicon, Intl., 3 Jul. 2008. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/113784.php>

APA
Kaiser. (2008, July 3). "GlaxoSmithKline, Novartis Found Guilty Of Overcharging Alabama Medicaid Program, Must Pay State $114M." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/113784.php.

Please note: If no author information is provided, the source is cited instead.


Medicare / Medicaid / SCHIP

What is Medicare / Medicaid?

Medicaid and Medicare are two governmental programs that provide medical and health-related services to specific groups of people in the United States. Although the two programs are very different, they are both managed by the Centers for Medicare and... Read more...

Most Popular Articles



Follow Our Medicare News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Medicare / Medicaid / SCHIP Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »